RAD51B, RAD51C, RAD51D, or RAD54L Mutations
1 clinical trials · Condition
◉ Watch RAD51B, RAD51C, RAD51D, or RAD54L Mutations
| Record | Firm | Date |
|---|---|---|
| Carboplatin or Olaparib for BRcA Deficient Prostate Cancer (NCT04038502) | VA Office of Research and Development | 2019-10-01 |
Track RAD51B, RAD51C, RAD51D, or RAD54L Mutations automatically
Every clearance here is in the API, with alerts when new ones post.